Home > Compound List > Compound details
167933-07-5 molecular structure
click picture or here to close

1-(2-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one

ChemBase ID: 798529
Molecular Formular: C20H21F3N4O
Molecular Mass: 390.4021496
Monoisotopic Mass: 390.16674597
SMILES and InChIs

SMILES:
c12[nH]c(=O)n(c1cccc2)CCN1CCN(CC1)c1ccc(cc1)C(F)(F)F
Canonical SMILES:
O=c1[nH]c2c(n1CCN1CCN(CC1)c1ccc(cc1)C(F)(F)F)cccc2
InChI:
InChI=1S/C20H21F3N4O/c21-20(22,23)15-5-7-16(8-6-15)26-12-9-25(10-13-26)11-14-27-18-4-2-1-3-17(18)24-19(27)28/h1-8H,9-14H2,(H,24,28)
InChIKey:
CCIZQGRSEAHATK-UHFFFAOYSA-N

Cite this record

CBID:798529 http://www.chembase.cn/molecule-798529.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
1-(2-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one
IUPAC Traditional name
flibanserin
Synonyms
3-(2-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1h-benzimidazol-2-one
CAS Number
167933-07-5

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
A&J Pharmtech AJA-O11476 external link Add to cart
Data Source Data ID Price
A&J Pharmtech
AJA-O11476 external link Add to cart Please log in.
Data Source Data ID

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 12.910018  H Acceptors
H Donor LogD (pH = 5.5) 2.2655401 
LogD (pH = 7.4) 3.6640685  Log P 3.8251414 
Molar Refractivity 103.6521 cm3 Polarizability 37.366352 Å3
Polar Surface Area 38.82 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Product Information Bioassay(PubChem)
Purity
97% expand Show data source

DETAILS

DETAILS

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle